These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 262180)

  • 21. Determination of disopyramide and mono-N-desisopropyl-disopyramide in serum by gas-liquid chromatography with nitrogen-selective detection.
    Brien JF; Nakatsu K; Armstrong PW
    J Pharmacol Methods; 1983 Jun; 9(4):295-308. PubMed ID: 6621050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enantioselective analysis of disopyramide and mono-N-dealkyldisopyramide in plasma and urine by high-performance liquid chromatography on an amylose-derived chiral stationary phase.
    Bortocan R; Lanchote VL; Cesarino EJ; Bonato PS
    J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):299-306. PubMed ID: 10993518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous analysis of disopyramide and quinidine in plasma by high-performance liquid chromatography.
    Ahokas JT; Davies C; Ravenscroft PJ
    J Chromatogr; 1980 Jul; 183(1):65-71. PubMed ID: 7400265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methods of assay of disopyramide in serum and urine (author's transl)].
    Mallein R; Boucherat M; Rondelet J; Pignat M; Ksavrelof H
    Ann Pharm Fr; 1978; 36(11-12):655-62. PubMed ID: 754645
    [No Abstract]   [Full Text] [Related]  

  • 25. The determination of disopyramide in blood plasma and urine.
    Daniel JW; Subramanian G
    J Int Med Res; 1976; 4(1 Suppl):2-4. PubMed ID: 1026523
    [No Abstract]   [Full Text] [Related]  

  • 26. Automated determination of disopyramide and N-monodealkyldisopyramide in plasma by reversed-phase liquid chromatography with a column switching system.
    Del Cont Bernard A; Royer Morrot MJ; Zhiri A; Rambourg M; Royer RJ
    J Chromatogr; 1992 Feb; 574(2):365-8. PubMed ID: 1618974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in human plasma by capillary electrophoresis.
    Jabor VA; Lanchote VL; Bonato PL
    Electrophoresis; 2001 Apr; 22(7):1406-12. PubMed ID: 11379964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of disopyramide phosphate in serum by high-performance liquid chromatography.
    Swezey CB; Ponzo JL
    Ther Drug Monit; 1984; 6(2):211-4. PubMed ID: 6429911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and dynamics of disopyramide and its dealkylated metabolite in healthy subjects.
    Chiang WT; von Bahr C; Calissendorff B; Dahlqvist R; Emilsson H; Magnusson A; Schenck-Gustafsson K
    Clin Pharmacol Ther; 1985 Jul; 38(1):37-44. PubMed ID: 4006374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
    Raghow G; Meyer MC; Straughn AB
    Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a high pressure liquid chromatographic analysis and an enzyme immunoassay technique for quantitation of disopyramide in serum or plasma.
    Bryson SM; Betts A; Summer DJ; Whiting B
    J Clin Hosp Pharm; 1982 Jun; 7(2):119-26. PubMed ID: 7050181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A HPLC method for the simultaneous determination of disopyramide, lidocaine and their monodealkylated metabolites.
    Angelo HR; Bonde J; Kampmann JP; Kastrup J
    Scand J Clin Lab Invest; 1986 Nov; 46(7):623-7. PubMed ID: 3787162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disopyramide and its N-monodesalkyl metabolite in breast milk.
    Barnett DB; Hudson SA; McBurney A
    Br J Clin Pharmacol; 1982 Aug; 14(2):310-2. PubMed ID: 7104189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid and sensitive liquid chromatography/tandem mass spectrometry assay for simultaneous quantitation of disopyramide and its major metabolite, mono-isopropyl-disopyramide, in rat plasma and its application to a pharmacokinetic study.
    Pham QK; Seo H; Ahn SH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():154-159. PubMed ID: 30173081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence photometric determination of disopyramide and mono-N-dealkylated disopyramide in plasma after separation by thin-layer chromatography.
    Gupta RN; Eng F; Lewis D; Kumana C
    Anal Chem; 1979 Mar; 51(3):455-8. PubMed ID: 532975
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effects of disopyramide and its mono-N-dealkylated metabolite in conscious dogs with chronic atrioventricular block: plasma concentration-response relationships.
    Dubray C; Boucher M; Paire M; Pinatel H; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1986; 8(6):1229-34. PubMed ID: 2434751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An HPLC method for the simultaneous quantitation of quinidine, procainamide, N-acetylprocainamide, and disopyramide.
    Bridges RR; Jennison TA
    J Anal Toxicol; 1983; 7(2):65-8. PubMed ID: 6190040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticholinergic activity in the serum of patients receiving maintenance disopyramide therapy.
    Iisalo E; Aaltonen L
    Br J Clin Pharmacol; 1984 Mar; 17(3):325-9. PubMed ID: 6712865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saliva concentrations of disopyramide cannot substitute the drug's plasma concentrations.
    Cordonnier J; Van den Heede M; Heyndrickx A
    J Anal Toxicol; 1987; 11(4):179-81. PubMed ID: 3626531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple gas-liquid chromatographic method for the measurement of disopyramide in blood-plasma or serum and in urine.
    Hayler AM; Flanagan RJ
    J Chromatogr; 1978 Jun; 153(2):461-71. PubMed ID: 659563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.